{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(1)"],"submitter":["Yu H"],"pubmed_abstract":["<h4>Background</h4>Opioids remain the mainstream therapy for post-surgical pain. The choice of opioids administered by patient-controlled intravenous analgesia (PCIA) for thoracoscopic lung surgery is unclear. This study compared 3 opioid analgesics for achieving satisfactory analgesia with minimal emesis (SAME).<h4>Methods</h4>This randomized clinical trial enrolled patients scheduled for thoracoscopic lung surgery randomized to receive 1 of 3 opioids for PCIA: oxycodone (group O), hydromorphone (group H), and sufentanil (group S). The primary outcome was the proportion of subjects achieving SAME, i.e., no-to-mild pain (pain score < 4/10) with minimal nausea/vomiting (PONV score < 2/4) when coughing during the pulmonary rehabilitation exercise in the first 3 postoperative days.<h4>Results"],"journal":["BMC anesthesiology"],"pagination":["253"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9358799"],"repository":["biostudies-literature"],"pubmed_title":["Patient-controlled intravenous analgesia with opioids after thoracoscopic lung surgery: a randomized clinical trial."],"pmcid":["PMC9358799"],"pubmed_authors":["Tian W","Mao W","Jiang R","Chen Y","Yu H","Xu Z","Jin L"],"additional_accession":[]},"is_claimable":false,"name":"Patient-controlled intravenous analgesia with opioids after thoracoscopic lung surgery: a randomized clinical trial.","description":"<h4>Background</h4>Opioids remain the mainstream therapy for post-surgical pain. The choice of opioids administered by patient-controlled intravenous analgesia (PCIA) for thoracoscopic lung surgery is unclear. This study compared 3 opioid analgesics for achieving satisfactory analgesia with minimal emesis (SAME).<h4>Methods</h4>This randomized clinical trial enrolled patients scheduled for thoracoscopic lung surgery randomized to receive 1 of 3 opioids for PCIA: oxycodone (group O), hydromorphone (group H), and sufentanil (group S). The primary outcome was the proportion of subjects achieving SAME, i.e., no-to-mild pain (pain score < 4/10) with minimal nausea/vomiting (PONV score < 2/4) when coughing during the pulmonary rehabilitation exercise in the first 3 postoperative days.<h4>Results","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2025-04-04T08:44:58.905Z","creation":"2025-04-04T08:44:58.905Z"},"accession":"S-EPMC9358799","cross_references":{"pubmed":["35941536"],"doi":["10.1186/s12871-022-01785-4"]}}